Amalgamated Bank’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,248
Closed -$21K 2500
2025
Q4
$21K Sell
1,248
-106
-8% -$1.51K ﹤0.01% 2092
2025
Q3
$16K Hold
1,354
﹤0.01% 2240
2025
Q2
$13K Hold
1,354
﹤0.01% 2326
2025
Q1
$8K Buy
1,354
+264
+24% +$1.6K ﹤0.01% 2481
2024
Q4
$9K Hold
1,090
﹤0.01% 2491
2024
Q3
$20K Hold
1,090
﹤0.01% 2141
2024
Q2
$11K Hold
1,090
﹤0.01% 2401
2024
Q1
$12K Sell
1,090
-1,734
-61% -$14.7K ﹤0.01% 2362
2023
Q4
$26K Buy
2,824
+249
+10% +$2.15K ﹤0.01% 2535
2023
Q3
$27K Hold
2,575
﹤0.01% 2516
2023
Q2
$37K Sell
2,575
-659
-20% -$7.6K ﹤0.01% 2447
2023
Q1
$23K Sell
3,234
-339
-9% -$2.98K ﹤0.01% 2598
2022
Q4
$40K Hold
3,573
﹤0.01% 2522
2022
Q3
$40K Buy
3,573
+55
+2% +$524 ﹤0.01% 2556
2022
Q2
$30K Buy
3,518
+209
+6% +$2.15K ﹤0.01% 2721
2022
Q1
$45K Buy
+3,309
New +$53.5K ﹤0.01% 2535

Other funds holding PHAT